Pfizer submits vitiligo data for oral drug approval
Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.
ADARx Raises $535M in IPO for RNA-Targeted Therapies
ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.
IL-17 Inhibitors Show Low IBD Risk in HS Patients
IL-17 inhibitors show low IBD risk in HS patients, according to a recent review in JAMA Dermatology.
Drexel study finds three ways music relieves pain
Drexel study finds three ways music relieves pain, offering new insights into music-based interventions for managing physical discomfort.
Northwell reports 75% rise in 9/11-linked cancer cases
Northwell reports a 75% rise in 9/11 cancer cases among Health Program patients, underscoring escalating health risks on the attack’s…
Brain Injury Camp Zips Ahead Despite Federal Uncertainty
Despite federal uncertainty, Camp Cranium unites brain injury camp survivors for healing. Discover the inspiring stories from rural Pennsylvania.
Older Pedestrians Suffer Higher Fatalities in Collisions
Senior pedestrian fatalities are rising as older walkers face a higher risk of death in vehicle crashes, exposing urgent safety…
DNA in Wastewater Reveals Community Dietary Habits
Discover how food DNA wastewater analysis can reveal community dietary habits, offering a rapid, survey‑free insight into what residents eat…
Iron-rich millet boosts toddler health safely
Discover how iron-rich millet safely boosts toddler health, improving iron levels and gut microbiome without digestive issues.
Cargill postbiotic reduces inflammation within hours
Cargill postbiotic EpiCor rapidly reduces inflammation markers and boosts immune health in a new clinical trial involving adults.